Your Messages Inbox
Your Article Summary
See Latest ArticlesMORE-CARE Trial to Assess Remote Monitoring Impact on Heart Failure Patients and Healthcare Utilization
Medtronic, 06/23/09
More than 22 million people worldwide have heart failure, a chronic condition in which the heart is unable to adequately pump blood throughout the body. Today, Medtronic, Inc. announced the first worldwide enrollments in the MORE-CARE trial, which will compare two disease management strategies for heart failure patients treated with an implantable device for cardiac resynchronization therapy. MORE-CARE aims to demonstrate that remote monitoring of these patients via the Medtronic CareLink Network is superior to in-office visits alone, in terms of clinical effectiveness and healthcare system utilization.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Article Search
Sponsor